Doceree today announced a $35 million Series B round led by Creaegis. Existing investors, Eight Roads Ventures and F-Prime Capital also participated in the round, the company notified in a statement.
The funds will enable Doceree to accelerate product development, augment technologies, scale global expansion and expand tea, it mentioned.
“We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targetting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the lifesciences industry. The investment speaks volumes about the value we are creating in the space,” said Harshit Jain, MD, founder and Global CEO, Doceree, in the statement.
Adding to it, Prakash Parthasarathy, Managing Partner and CIO, and Nitish Bandi, Partner, Creaegis, said, “We are excited to partner with Harshit and the Doceree team to support the company in its next phase of growth led by a digital platform driven by deep learning-based data models. Our past experience of investing in pioneering global SaaS companies and in the healthcare ecosystem will enable us to support the company’s mission to create superior outcomes for pharma brands, providers and patients.”
